معرفی
Patrycja Gradowska is an active researcher in the Department of Hematology at Erasmus University Medical Center, specializing in acute myeloid leukemia (AML) research. Her work focuses on prognostic modeling, minimal residual disease assessment, and risk stratification in AML patients, particularly in relapsed cases and elderly populations.
Her research interests span multiple critical areas in hematology including leukemia stem cell identification using markers like CD133, computational approaches to measurable residual disease assessment, and precision medicine applications in hematological malignancies. She employs advanced methodologies including mixture models for flow cytometry data analysis and develops data management systems for personalized treatment approaches.
Analysis of her publication trends reveals strong emphasis on clinical applicability of research findings, with particular attention to patient stratification, treatment response prediction, and survival outcomes. Her work frequently addresses challenges in elderly AML patients and relapsed disease scenarios, contributing to evidence-based clinical decision frameworks.
Dr. Gradowska actively collaborates with leading hematology researchers across international institutions, as evidenced by her co-authorship with prominent figures including Löwenberg, Ossenkoppele, and Valk. Her research demonstrates significant impact through citations, media coverage, and engagement across academic social platforms.
Her scholarly contributions extend beyond traditional publication metrics to include digital engagement through platforms like Mendeley and X, with her work being referenced by diverse academic communities and picked up by news outlets covering medical advancements.
